Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
C3788 trans-Urocanic AcidSummary: A compound that can inhibit natural killer cell activity in vitro and modulate immune function. -
C3790 N1,N12-Diacetylspermine (hydrochloride)Summary: A potential biomarker for early cancer detection and diagnosis. -
C3825 5-Methyl-2'-deoxycytidineSummary: Promotes de novo DNA methylation in a cis-acting manner and regulates gene transcription. -
C3834 Hexacosanoic AcidSummary: A 26-carbon saturated fatty acid -
C3842 Glycolithocholic Acid (sodium salt)Summary: A sodium salt of a glycine-conjugated secondary bile acid for research on hepatoenteric diseases. -
C3874 1-Stearoyl-2-lyso-sn-glycero-3-PCSummary: A phospholipid biochemical reagent for membrane biology research and lipid metabolism analysis. -
C3879 4-hydroperoxy CyclophosphamideSummary: Active metabolite form of the prodrug Cyclophosphamide -
C3890 2,7-Dichlorodihydrofluorescein diacetateSummary: An indicator for peroxynitrite formation -
C3893 Sodium OxamateSummary: An inhibitor of glycolysis and gluconeogenesis -
C3895 Lignoceric CeramideSummary: A long-chain sphingolipid molecule that can induce membrane rearrangement and regulate membrane fluidity and signal transduction.

